Radiation oncology management of stage III and IVA cervical carcinoma.
Int J Gynecol Cancer
; 32(3): 231-238, 2022 03.
Article
em En
| MEDLINE
| ID: mdl-35256408
ABSTRACT
Worldwide, stage III-IVA carcinomas of the uterine cervix comprise a significant proportion of cases at presentation, and have a higher rate of recurrence and worse overall survival. This review will discuss the epidemiology, prevention strategies, clinical presentation, and treatment recommendations for stage III-IVA cervical cancer. The focus will be on the role of radiation therapy, concurrent chemoradiotherapy, and brachytherapy, including the potential benefits and anticipated toxicities. The unique challenges and considerations of fistula formation and approaches to management will be highlighted, and follow-up care and future directions discussed. As low and middle income countries bear the highest burden of advanced stage carcinoma of the uterine cervix, this review will address the unique needs of global communities.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Braquiterapia
/
Neoplasias do Colo do Útero
/
Radioterapia (Especialidade)
Tipo de estudo:
Guideline
Limite:
Female
/
Humans
Idioma:
En
Revista:
Int J Gynecol Cancer
Ano de publicação:
2022
Tipo de documento:
Article